Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2012
12/26/2012CN102844042A Novel use of polygonatum falcatum or polygonatum sibiricum extract
12/26/2012CN102844040A 内脏脂肪蓄积抑制剂 The visceral fat accumulation inhibitor
12/26/2012CN102844038A Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
12/26/2012CN102839187A miR-29 absorption sequence, absorption carrier and uses thereof
12/26/2012CN102839185A Construction method and application technology of rolGLP-HV engineering bacterium
12/26/2012CN102838687A Extraction method for beta-glucan in oat bran
12/26/2012CN102838669A Valosin fragment, and preparation method and application thereof
12/26/2012CN102838651A Oleanolic acid derivatives, and preparation method and application thereof
12/26/2012CN102838599A Polymorphs
12/26/2012CN102838596A Pyrrolo[2,3-b]pyridine derivative, preparation method and application thereof
12/26/2012CN102838546A Pyrazole derivatives as modulators of 5-ht2a serotonin receptor useful for treatment of disorders related thereto
12/26/2012CN102838532A Novel compounds for a treatment of diseases associated with amyloid or amyloid-like proteins
12/26/2012CN102838505A Amide compound and preparation method as well as application thereof
12/26/2012CN102838485A Ilex latifolia thunb extract
12/26/2012CN102836390A Weight-reducing medicine for external use
12/26/2012CN102836379A Traditional Chinese medicine compound preparation for reducing lipid and dispelling effects of alcohol as well as preparation method and application of same
12/26/2012CN102836358A Traditional Chinese medicine composition for treating prediabetes
12/26/2012CN102836353A Chinese medicine for treating diabetes
12/26/2012CN102836349A Traditional Chinese medicine composition for treating diabetes and preparation method thereof
12/26/2012CN102836339A Medicine for treating diabetic nephropathy
12/26/2012CN102836329A Chinese medicinal composition for treating diabetic nephropathy
12/26/2012CN102836322A Chinese medicine for treating diabetes
12/26/2012CN102836282A Application of folium lycii total flavone extract
12/26/2012CN102836281A Application of lycium ruthenicum murray total flavone extract
12/26/2012CN102836280A Folium Lycii total flavone extract and preparation method thereof
12/26/2012CN102836265A Litchi seed dropping pill and preparation method thereof
12/26/2012CN102836264A Medicinal liquor capable of reducing blood sugar and preventing and treating diabetic complications
12/26/2012CN102836238A Toxin-removing and weight-reducing health care product
12/26/2012CN102836236A Ultrahigh-pressure extraction method of hovenia dulcis general flavone
12/26/2012CN102836204A Kudzuvine root extracts and preparation thereof
12/26/2012CN102836194A Extraction method of affine cudweed total flavonoids
12/26/2012CN102836188A Folium microcotis total flavone extract and preparation method and application thereof
12/26/2012CN102836181A Antradiacomphora oral liquid and preparation method thereof
12/26/2012CN102836175A Artificial bear bile
12/26/2012CN102836172A Powder combination containing glucose
12/26/2012CN102516079B Synthetic method of novel ferulic acid derivative
12/26/2012CN102406943B Polyethylene glycol chemically modified compound of human fibroblast growth factor-21 (FGF-21) and preparation method thereof
12/26/2012CN102225078B 抗肥胖剂及抗肥胖食品 Antiobesity agents and anti-obesity food
12/26/2012CN102138921B Application of phthalimide derivatives in preparation of anti-angiogenesis medicaments
12/26/2012CN102125127B Functional highland barley red yeast rice tea and preparation method thereof
12/26/2012CN102114018B Compound controlled-release tablet with effect of regulating blood lipid and preparation method thereof
12/26/2012CN102100685B PTP1B inhibitor and synthetic method and application thereof
12/26/2012CN102000170B Weight-reducing composition and preparation method thereof
12/26/2012CN102000063B Application of E ring benzyloxy substituted silybin in preparing glycosidase inhibitors
12/26/2012CN102000061B Medicinal application of nitrobenzoyl silybin in preparation of glycosidase inhibitor
12/26/2012CN102000058B Application of B/E ring changed silybin in preparing glycosidase inhibitors
12/26/2012CN102000056B Pharmaceutical application of B ring methoxy substituted silybin in preparing glycosidase inhibitors
12/26/2012CN101914092B Azabicyclo alkane derivative and preparation method and application thereof in medicaments
12/26/2012CN101855214B Benzimidazole derivatives and their use as FXR agonists
12/26/2012CN101837011B Medicinal composition for treating diabetes
12/26/2012CN101835478B Laxative agent
12/26/2012CN101815716B Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
12/26/2012CN101633623B Method for extracting mulberry leaf gamma-aminobutyric acid and application thereof
12/26/2012CN101524377B Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof
12/26/2012CN101454006B Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
12/26/2012CN101342303B Pure natural medicament for treating diabetes
12/26/2012CN101312952B 四氢-环戊二烯并吡唑大麻素调节剂 Tetrahydro - cyclopenta pyrazole cannabinoid modulators
12/26/2012CN101139392B KDR peptides and vaccines containing the same
12/26/2012CN101106914B Novel nutraceutical compositions
12/26/2012CN100998864B Cyclosporin A semisolid skeleton capsule
12/25/2012US8338403 Drug for improving hyperglycemia
12/25/2012US8338401 Coumarin-amide derivatives and its preparation, said drug composition and its use
12/25/2012US8338369 Methods for administering long-lasting hypoglycemic agents
12/25/2012US8338363 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
12/25/2012US8337915 Fenugreek seed extract to lower blood cholesterol
12/25/2012US8337834 Methods of making enhanced, autologous fat grafts
12/25/2012US8337829 Conditioned medium and proliferated cell lines produced therefrom
12/20/2012WO2012174480A2 Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme
12/20/2012WO2012174476A2 Antisense modulation of fibroblast growth factor receptor 4 expression
12/20/2012WO2012174365A2 Methods for producing pancreatic precursor cells and uses thereof
12/20/2012WO2012174362A1 Pyrazole derivatives as cannabinoid receptor 1 antagonists
12/20/2012WO2012174359A1 Methods for increasing insulin sensitivity and treating diabetes
12/20/2012WO2012174285A2 Inhibitor probes for imaging sodium-glucose cotransporters in health and disease
12/20/2012WO2012174280A2 Methods and compositions for modulating myofibroblast activities
12/20/2012WO2012174262A2 Formulations and methods of treating subjects having central nervous system, endocrine, inflammatory or cardiovascular disorders or at-risk thereof with highly purified omega-3 fatty acid formulations
12/20/2012WO2012174229A2 Methods for the synthesis and purification of deoxycholic acid
12/20/2012WO2012174178A1 Anti-angptl3 antibodies and uses thereof
12/20/2012WO2012174164A2 Agonists of gpr131 and uses thereof
12/20/2012WO2012174035A2 A nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine
12/20/2012WO2012173952A1 Piperazine derivatives, compositions, and uses related thereto
12/20/2012WO2012173819A2 Anti-cd3 therapies
12/20/2012WO2012173422A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
12/20/2012WO2012173410A2 Novel c-aryl ansa sglt2 inhibitors
12/20/2012WO2012173226A1 Pharmaceutical preparation containing polystyrenesulfonic acid salt
12/20/2012WO2012173219A1 Novel biaryl ether derivative
12/20/2012WO2012173174A1 Azaspiroalkane compound
12/20/2012WO2012173163A1 Crushed cells and composition thereof
12/20/2012WO2012173099A1 Endothelial-lipase-inhibiting amino derivative
12/20/2012WO2012172473A1 Cysteine protease inhibitors
12/20/2012WO2012171479A1 Oxazolidinone compounds and their uses in preparation of antibiotics
12/20/2012WO2012171125A1 N,n,n-trialkylpolymers, methods of their preparation and uses thereof
12/20/2012WO2012171114A1 Synthetic epigallocatechin gallate (egcg) analogs
12/20/2012WO2012171084A1 Polymer insulin encapsulation system, process and use of said system
12/20/2012WO2012148252A3 Metformin-based ionic co-crystals
12/20/2012WO2012004653A8 Method for inhibition of nf-kb gene expression
12/20/2012US20120323003 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
12/20/2012US20120322885 Materials and Methods for Improving Alcohol Metabolism and Alleviating the Effects of Hangovers
12/20/2012US20120322880 Pharmaceutical Formulations of Modafinil
12/20/2012US20120322875 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/20/2012US20120322868 Food products, preparation, and therapeutic methods